NEW YORK (GenomeWeb News) – Roche today reported that its molecular diagnostics sales rose 5 percent and its applied science revenues increased 8 percent year over year for the first half of 2009.

The Swiss pharmaceuticals, diagnostics, and life sciences firm reported molecular diagnostic sales of CHF594 million (US$553.8 million), up 5 percent, while its applied science business brought in revenues of CHF 403 million, an increase of 8 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.